Botanical species · safety record

Cinnamomum burmanni

The EFSA Compendium of Botanicals holds 16 constituent measurements for Cinnamomum burmanni. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Cinnamomum burmanni (Nees & T.Nees) Blume

16Constituent measurements

0Safety records

5Cited sources

0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Asarinin	Stem / stalk	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Camphor	Stem / stalk	Solvent extraction	—	GC-MS	No resolvable identifier
Cinnamaldehyde	Bark	Solvent extraction	≥ 12.4 Gram/kilogram	Mass Spectroscopy and hyphenated methods without chromatography	No resolvable identifier
Cinnamaldehyde	Bark	Solvent extraction	≤ 63.8 Gram/kilogram	Mass Spectroscopy and hyphenated methods without chromatography	No resolvable identifier
Cinnamaldehyde	Bark	Solvent extraction	0.054 Percent	HPLC with standard detection methods	No resolvable identifier
Cinnamaldehyde	Leaves	Essential oil	60.17 Percent	GC-MS	No resolvable identifier
Coumarin	Stem / stalk	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Coumarin	Leaves	Essential oil	13.39 Percent	GC-MS	No resolvable identifier
Coumarin	Bark	Solvent extraction	0.042 Percent	HPLC with standard detection methods	No resolvable identifier
Coumarin	Bark	Solvent extraction	≤ 9.3 Gram/kilogram	Mass Spectroscopy and hyphenated methods without chromatography	No resolvable identifier
Coumarin	Bark	Solvent extraction	≥ 2.14 Gram/kilogram	Mass Spectroscopy and hyphenated methods without chromatography	No resolvable identifier
Eugenol	Leaves	Essential oil	17.62 Percent	GC-MS	No resolvable identifier
Eugenol	Bark	Solvent extraction	< 0.05 Gram/kilogram	Mass Spectroscopy and hyphenated methods without chromatography	No resolvable identifier
Naphthalene derivatives	Stem / stalk	Solvent extraction	—	GC-MS	No resolvable identifier
Scopoletin	Stem / stalk	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Syringaresinol	Stem / stalk	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Thantsin, Khin., Zhang, Qin., Yang, Jie., Wang, Qiang. Composition of semivolatile compounds of 10 Cinnamomum species from China and Myanmar. Natural Product Research, 2008, p. 576-583.
Wang, Yan-Hong., Avula, Bharathi., Nanayakkara, N. P. Dhammika., Zhao, Jianping., Khan, Ikhlas A. Cassia Cinnamon as a Source of Coumarin in Cinnamon-Flavored Food and Food Supplements in the United States. Journal of Agricultural and Food Chemistry, 2013, p. 4470-4476.
Chen, Chung-Yi., Hong, Zi-Ling., Yang, Woei-Ling., Wu, Ming-Hsiu., Huang, Jin-Cherng., Lee, Jun-Yen. A novel homosesquiterpenoid from the stems of Cinnamomum burmanii. Natural Product Research, 2012, p. 1218-1223.
Wang, Rui., Wang, Ruijiang., Yang, Bao. Extraction of essential oils from five cinnamon leaves and identification of their volatile compound compositions. Innovative Food Science Emerging Technologies, 2009, p. 289-292.
Archer, Alan W. Determination of cinnamaldehyde, coumarin and cinnamyl alcohol in cinnamon and cassia by high-performance liquid chromatography. Journal of Chromatography, 1988, p. 272-276.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature